Skip to main content

GDU LC 2023 Main banner

Full Schedule

Full Schedule

Type here to filter the list

Thursday, May 4, 2023
8:00 AM – 8:15 AM ET
Welcome

8:15 AM – 9:00 AM ET
Session 1: Birdseye View of the Current Treatment Landscape in Metastatic NSCLC without Actionable Mutations

9:00 AM – 9:45 AM ET
Session 2: Special Topic –EGFR Mutation
Presenter: Heather Wakelee, MD – Stanford University

9:45 AM – 10:45 AM ET
A Treatment Option for Patients With Resectable NSCLC Dual Immunotherapy + Platinum-Based Chemotherapy for the Treatment of mNSCLC

10:45 AM – 11:00 AM ET
Exhibit Hall

11:00 AM – 11:45 AM ET
Session 3: EGFR: The Challenge of Primary and Secondary Resistance

11:45 AM – 12:30 PM ET
Session 4: Targeting ALK and ROS1: A Fusion Paradigm
Presenter: Jyoti Patel, MD – Northwestern University

12:30 PM – 1:30 PM ET
The Evolving Role of Biomarkers in Advanced NSCLC - Speaker: Erin Bertino, MD

1:30 PM – 2:15 PM ET
Session 5: Targeting RET, NTRK, and NRG1
Presenter: Marina Garassino, MD – University of Chicago

2:15 PM – 3:00 PM ET
Session 6: The Emergence of ADC: Will ADCs Alter the Therapeutic Landscape?

3:00 PM – 3:30 PM ET
Exhibit Hall

3:30 PM – 4:15 PM ET
Session 7: The Primacy of Front-Line Checkpoint Inhibitors in NSCLC
Presenter: Jyoti Patel, MD – Northwestern University

4:15 PM – 5:15 PM ET
KOL Round Table
Presenter: Edward B. Garon, MD, MS – University of California, Los Angeles
Presenter: Helen J. Ross, MD – Rush University
Presenter: Corey J. Langer, MD, FACP – Abramson Cancer Center, Hospital of the University of Pennsylvania
Presenter: Barbara Melosky, MD – Bc Cancer
Presenter: Jyoti Patel, MD – Northwestern University